Phosphoproteomics identifies oncogenic Ras signaling targets and their involvement in lung adenocarcinomas.
BACKGROUND:Ras is frequently mutated in a variety of human cancers, including lung cancer, leading to constitutive activation of MAPK signaling. Despite decades of research focused on the Ras oncogene, Ras-targeted phosphorylation events and signaling pathways have not been described on a proteome-w...
Main Authors: | Putty-Reddy Sudhir, Chia-Lang Hsu, Mei-Jung Wang, Yi-Ting Wang, Yu-Ju Chen, Ting-Yi Sung, Wen-Lian Hsu, Ueng-Cheng Yang, Jeou-Yuan Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3102680?pdf=render |
Similar Items
-
RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma
by: Philip East, et al.
Published: (2022-09-01) -
Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas.
by: Phuoc T Tran, et al.
Published: (2008-05-01) -
RAS: Striking at the Core of the Oncogenic Circuitry
by: Ryan C. Gimple, et al.
Published: (2019-09-01) -
The Role of Wild-Type RAS in Oncogenic RAS Transformation
by: Erin Sheffels, et al.
Published: (2021-04-01) -
RAS oncogenes direct metastasis
by: Magda Spella, et al.
Published: (2017-09-01)